ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Clinical trial NCT04247542 · COMPLETED

Trial details

NCT number: NCT04247542
Sponsor: Acurx Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2020-03-06
Primary completion: 2023-10-03
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.